Form 4: Precigen Director Dean Mitchell Acquires Shares and Stock Units in Lieu of Retainer
SEC Form 4 Filing
Director Dean Mitchell acquired shares and restricted stock units of Precigen, Inc. in lieu of an annual retainer.
Summary
- On March 14, 2024, Dean J. Mitchell, a director of Precigen, Inc., acquired 39,510 shares of common stock at a price of $1.43 per share in lieu of an annual retainer of $56,499.
- Following this transaction, Mitchell directly owns 503,183 shares of Precigen common stock.
- Mitchell also acquired 87,412 restricted stock units (RSUs), each representing a contingent right to receive one share of Precigen common stock, which vest in full on March 14, 2025.
- Additionally, Mitchell acquired an option to purchase 101,626 shares of common stock at an exercise price of $1.43, expiring on March 14, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The director's acquisition of shares could be interpreted as a slightly positive signal, but it's primarily a routine filing.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of RSUs on March 14, 2025, represents a future event.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Directors often receive stock or stock options as part of their compensation.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of transaction: acquisition of common stock, restricted stock units, and stock options. |
| 03/14/2025 | Vesting date for the 87,412 restricted stock units. |
| 03/14/2034 | Expiration date for the option to purchase 101,626 shares of common stock. |
| 03/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.